The lancet. Gastroenterology & hepatology
-
Lancet Gastroenterol Hepatol · Nov 2020
Multicenter StudyOutcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
Despite concerns that patients with liver transplants might be at increased risk of adverse outcomes from COVID-19 because of coexisting comorbidities and use of immunosuppressants, the effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on this patient group remains unclear. We aimed to assess the clinical outcomes in these patients. ⋯ European Association for the Study of the Liver, US National Institutes of Health, UK National Institute for Health Research.